LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-1.67%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.07B
AUM Growth
-$529M
(-15%)
Cap. Flow
-$327M
Cap. Flow
% of AUM
-10.65%
Top 10 Holdings %
Top 10 Hldgs %
53.48%
Holding
600
New
258
Increased
39
Reduced
96
Closed
156
Top Buys
| 1 |
HES
Hess
HES
|
$346M |
| 2 |
X
US Steel
X
|
$170M |
| 3 |
HubSpot
HUBS
|
$167M |
| 4 |
ANSS
Ansys
ANSS
|
$166M |
| 5 |
Chevron
CVX
|
$141M |
Top Sells
| 1 |
Kenvue
KVUE
|
$128M |
| 2 |
Adobe
ADBE
|
$97.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$84M |
| 4 |
BP
BP
|
$78.5M |
| 5 |
Apple
AAPL
|
$71.3M |
Sector Composition
| 1 | Technology | 29.42% |
| 2 | Healthcare | 20.77% |
| 3 | Energy | 16.72% |
| 4 | Consumer Discretionary | 8.58% |
| 5 | Financials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Recursion Pharmaceuticals
RXRX
$1.97B
| $21.8M | 0.26% |
2,901,134
+1,993,518
| +220% | +$15M |
|
27
Cadence Design Systems
CDNS
$95.2B
| $21.2M | 0.25% |
68,792
+792
| +1% | +$244K |
|
28
iShares Russell 2000 ETF
IWM
$67.4B
| $21M | 0.25% |
+103,608
| New | +$21M |
|
29
Danaher
DHR
$143B
| $20.9M | 0.25% |
83,829
-112,234
| -57% | -$28M |
|
30
Fortinet
FTNT
$58.6B
| $17.8M | 0.21% |
+295,554
| New | +$17.8M |
|
31
Enphase Energy
ENPH
$4.78B
| $17.7M | 0.21% |
+177,766
| New | +$17.7M |
|
32
89bio
ETNB
$1.28B
| $17.5M | 0.21% |
2,180,931
-518,539
| -19% | -$4.15M |
|
33
Mineralys Therapeutics
MLYS
$2.2B
| $17M | 0.2% |
1,456,804
+152,588
| +12% | +$1.79M |
|
34
Capital One
COF
$145B
| $16.2M | 0.19% |
+116,730
| New | +$16.2M |
|
35
Crinetics Pharmaceuticals
CRNX
$3.23B
| $15.7M | 0.19% |
350,766
-279,416
| -44% | -$12.5M |
|
|
VRNA
36
Verona Pharma
VRNA
$9.19B
| $15.2M | 0.18% |
1,050,842
+168,802
| +19% | +$2.44M |
|
37
Bausch + Lomb
BLCO
$5.16B
| $15M | 0.18% |
1,033,880
| – | – |
|
38
Old Dominion Freight Line
ODFL
$31.3B
| $13.8M | 0.16% |
78,331
+11,921
| +18% | +$2.11M |
|
39
Comcast
CMCSA
$125B
| $13.6M | 0.16% |
+348,292
| New | +$13.6M |
|
40
Copart
CPRT
$48.3B
| $13.5M | 0.16% |
+250,170
| New | +$13.5M |
|
41
PepGen
PEPG
$42M
| $13.4M | 0.16% |
841,431
| – | – |
|
42
Pyxis Oncology
PYXS
$99.8M
| $12.8M | 0.15% |
3,861,179
| – | – |
|
43
Walt Disney
DIS
$214B
| $12.7M | 0.15% |
+127,850
| New | +$12.7M |
|
|
AUTL
44
Autolus Therapeutics
AUTL
$386M
| $12.7M | 0.15% |
3,646,230
+1,555,759
| +74% | +$5.41M |
|
45
Idexx Laboratories
IDXX
$51.2B
| $11.3M | 0.13% |
23,263
| – | – |
|
46
Agilent Technologies
A
$36.4B
| $11.2M | 0.13% |
+86,309
| New | +$11.2M |
|
47
Celldex Therapeutics
CLDX
$1.51B
| $10.8M | 0.13% |
290,850
+42,032
| +17% | +$1.56M |
|
48
Agios Pharmaceuticals
AGIO
$2.1B
| $10.7M | 0.13% |
248,395
-116,367
| -32% | -$5.02M |
|
|
SWTX
49
DELISTED
SpringWorks Therapeutics
SWTX
| $9.92M | 0.12% |
263,340
-108,734
| -29% | -$4.1M |
|
50
EyePoint Pharmaceuticals
EYPT
$819M
| $9.33M | 0.11% |
1,072,577
+443,181
| +70% | +$3.86M |
|